Distinguishing between haloperidol's and decamethonium's disruptive effects on operant behavior in rats: use of measurements that complement response rate.

Scientists gave two drugs to rats that pressed a lever for food. One drug was haloperidol, an antipsychotic. The other was decamethonium, a muscle relaxant.

The team wired the lever to record not just how many presses, but also how hard and how long each press lasted. They wanted to see if the drugs changed the tiny details of the movement.

Haloperidol made the rats press harder and longer, but the head and paw no longer moved in sync. Decamethonium made the presses weaker and shorter, yet the timing between body parts stayed normal.

Same drop in overall lever presses, two very different motor stories.

McClure et al. (2000) later showed that raising the force requirement on a timing task makes rats respond too early. Their work extends Duker et al. (1991) by proving that force itself can distort temporal control, not just the drug.

Cohen (1986) also dosed rats with haloperidol and found it did not follow the usual "resistance-to-change" rules. Both papers agree: haloperidol’s effect is special, not a simple slowdown.

McIntyre et al. (2002) and Glover et al. (1976) tested amphetamine and saw pure rate changes with no timing shift. This contrast looks like a contradiction, but the difference is measurement. The amphetamine papers only counted responses; C et al. added force and duration sensors, revealing motor versus motivational splits that rate alone can hide.

If you assess medication side effects or neurological decline in clients, attach a cheap force or duration gauge to the response device. A fall in rate could mean less motivation, weaker muscles, or distorted timing. The extra measure tells you which one, so your intervention can target the right deficit.